Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medico-GDM: Metformin vs control to prevent gestational diabetes in high-risk pregnant women
2014-000446-30Phase 3Terminated
- Sponsor
- Maasstad Ziekenhuis
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoint: Incidence of gestational diabetes mellitus. Started Apr 2014; status: terminated.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2014-000446-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000446-30.